References

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

10.1016/s1474-4422(09)70025-0 · 2009 · External reference

High Leukocyte Count and Risk of Poor Outcome After Subarachnoid Hemorrhage: A Meta-Analysis

10.1016/j.wneu.2019.12.056 · 2020 · External reference

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association

2012 · External reference

Study on the expression and mechanism of inflammatory factors in the brain of rats with cerebral vasospasm

2017 · External reference

Early release of high-mobility group box 1 (HMGB1) from neurons in experimental subarachnoid hemorrhage in vivo and in vitro

10.1186/1742-2094-11-106 · 2014 · External reference

Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage

10.1161/01.str.32.1.212 · 2001 · External reference

Expression change of interleukin-8 gene in rabbit basilar artery after subarachnoid hemorrhage

10.1007/s12264-007-0022-1 · 2007 · External reference

Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis

10.1016/j.wneu.2017.12.076 · 2018 · External reference

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

10.1136/jnnp.70.4.534 · 2001 · External reference

Expression of interleukin-1 beta in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm

10.1016/s0304-3940(01)02194-2 · 2001 · External reference

Compartmentalisation of the inflammatory response following aneurysmal subarachnoid haemorrhage

10.1016/j.cyto.2019.154778 · 2019 · External reference

Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients

10.3390/ijms21051569 · 2020 · External reference

Increased serum interleukin-33 concentrations predict worse prognosis of aneurysmal subarachnoid hemorrhage

10.1016/j.cca.2018.08.011 · 2018 · External reference

The relationship between IL-6, ET-1 and cerebral vasospasm, in experimental rabbit subarachnoid hemorrhage

10.23736/s0390-5616.16.03876-5 · 2019 · External reference

Interleukin-6 Levels in Cerebrospinal Fluid and Plasma in Patients with Severe Spontaneous Subarachnoid Hemorrhage

10.1016/j.wneu.2018.10.113 · 2019 · External reference

The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage

2011 · External reference

Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage

10.1038/s41598-020-79586-3 · 2021 · External reference

Shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: the role of intrathecal interleukin-6

10.1007/s12028-014-9991-x · 2014 · External reference

Role of Cerebrospinal Fluid Markers for Predicting Shunt-Dependent Hydrocephalus in Patients with Subarachnoid Hemorrhage and External Ventricular Drain Placement

10.1016/j.wneu.2018.09.159 · 2019 · External reference

Blocking Hepatoma-Derived Growth Factor Attenuates Vasospasm and Neuron Cell Apoptosis in Rats Subjected to Subarachnoid Hemorrhage

2021 · External reference

Effects of simvastatin and taurine on delayed cerebral vasospasm following subarachnoid hemorrhage in rabbits

10.3892/etm.2016.3082 · 2016 · External reference

Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage

10.2310/jim.0b013e3182686932 · 2012 · External reference

TNF-R1 Correlates with Cerebral Perfusion and Acute Ischemia Following Subarachnoid Hemorrhage

10.1007/s12028-020-01082-3 · 2020 · External reference

Elevated IL-6 and TNF-α Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients

10.1007/s12035-015-9268-1 · 2016 · External reference

Increase ICAM-1 and LFA-1 expression by cerebrospinal fluid of subarachnoid hemorrhage patients: involvement of TNF-α

10.1016/j.brainres.2013.03.041 · 2013 · External reference

10.1055/s-2005-923537

10.1055/s-2005-923537 · External reference

Inflammation, Cerebral Vasospasm, and Brain Injury in Subarachnoid Hemorrhage-A Shifting Paradigm and a New Beginning

10.1097/ccm.0000000000003373 · 2018 · External reference

Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review

10.3390/ijms17040497 · 2016 · External reference

Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage

10.3389/fneur.2018.00292 · 2018 · External reference

The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study

10.1097/00006123-199702000-00010 · 1997 · External reference

Cyclosporine A prevents neurological deterioration of patients with SAH—a preliminary report

10.1007/bf01402450 · 1991 · External reference

Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage

10.1227/00006123-198708000-00004 · 1987 · External reference

Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage

10.3171/2009.4.jns081377 · 2010 · External reference

Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage—results of a multi-center controlled double-blind clinical study

1988 · External reference

A Propensity Score Analysis of the Impact of Dexamethasone Use on Delayed Cerebral Ischemia and Poor Functional Outcomes After Subarachnoid Hemorrhage

10.1016/j.wneu.2017.10.051 · 2018 · External reference

Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients

10.1159/000475824 · 2017 · External reference

Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials

10.3171/2013.3.jns121436 · 2013 · External reference

Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial

10.3171/2012.9.jns12492 · 2013 · External reference

Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study

10.3171/2016.9.jns16615 · 2018 · External reference

The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

10.1186/1742-2094-11-1 · 2014 · External reference

Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

10.1016/j.ajem.2017.09.001 · 2017 · External reference

Antiplatelet therapy for aneurysmal subarachnoid haemorrhage

2007 · External reference

Reflex principles of immunological homeostasis

10.1146/annurev-immunol-020711-075015 · 2012 · External reference

Neural regulation of immunity: molecular mechanisms and clinical translation

10.1038/nn.4477 · 2017 · External reference

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

10.1038/nature01339 · 2003 · External reference

Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide

10.1186/s12950-016-0140-5 · 2016 · External reference

Non-invasive Vagus Nerve Stimulation Protects Against Cerebral Ischemia/Reperfusion Injury and Promotes Microglial M2 Polarization Via Interleukin-17A Inhibition

10.1007/s12031-018-1227-7 · 2019 · External reference

Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis

10.1111/joim.12626 · 2017 · External reference

Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis

2007 · External reference

Unresolved reference

2015 · External reference

A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease

10.1111/nmo.13911 · 2020 · External reference

Vagus Nerve Stimulation Attenuates Cerebral Microinfarct and Colitis-induced Cerebral Microinfarct Aggravation in Mice

10.3389/fneur.2018.00798 · 2018 · External reference

Noninvasive Vagus Nerve Stimulation Prevents Ruptures and Improves Outcomes in a Model of Intracranial Aneurysm in Mice

2019 · External reference

Current Directions in the Auricular Vagus Nerve Stimulation II ‐ An Engineering Perspective

10.3389/fnins.2019.00772 · 2019 · External reference

Current Directions in the Auricular Vagus Nerve Stimulation I ‐ A Physiological Perspective

10.3389/fnins.2019.00854 · 2019 · External reference

Unresolved reference

2013 · External reference

Improving the reporting of pragmatic trials: an extension of the CONSORT statement

10.1136/bmj.a2390 · 2008 · External reference

Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke

10.1016/j.brs.2022.10.012 · 2022 · External reference

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study

10.1080/03009742.2020.1764617 · 2021 · External reference

Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial

10.1111/ner.12398 · 2016 · External reference

Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external ear

10.1186/s42234-019-0020-4 · 2019 · External reference

Vagus Nerve Stimulation

10.1007/s40473-014-0010-5 · 2014 · External reference

Transcutaneous Vagus Nerve Stimulation (tVNS) Enhances Response Selection During Sequential Action

10.3389/fpsyg.2018.01159 · 2018 · External reference

Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical Practice

10.3389/fnins.2020.00284 · 2020 · External reference

Diagnosis of delayed cerebral ischaemia and cerebral vasospasm in subarachnoid haemorrhage

10.1016/j.nrl.2009.12.006 · 2010 · External reference

Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage

2019 · External reference

Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis

10.1073/pnas.1605635113 · 2016 · External reference

Fundamentals of Biostatistics

2000 · External reference

Unresolved reference

2015 · External reference

Sample Size Calculation and Power Analysis of Time-Averaged Difference

10.22237/jmasm/1130803680 · 2005 · External reference

Unresolved reference

2013 · External reference